X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4269) 4269
Publication (536) 536
Newsletter (199) 199
Book Chapter (84) 84
Newspaper Article (70) 70
Book Review (44) 44
Dissertation (12) 12
Conference Proceeding (9) 9
Magazine Article (3) 3
Reference (3) 3
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2713) 2713
index medicus (1432) 1432
niemann-pick disease (1354) 1354
animals (1339) 1339
female (936) 936
male (930) 930
cholesterol (859) 859
biochemistry & molecular biology (796) 796
mice (783) 783
cholesterol - metabolism (637) 637
niemann-pick diseases - metabolism (525) 525
niemann-pick diseases - pathology (490) 490
adult (481) 481
lipids (478) 478
mutation (474) 474
niemann-pick-disease (474) 474
child (443) 443
niemann-pick diseases - genetics (427) 427
cell biology (409) 409
infant (407) 407
child, preschool (386) 386
pick's disease (383) 383
genetics & heredity (380) 380
neurosciences (366) 366
niemann-pick diseases - diagnosis (329) 329
cells, cultured (327) 327
adolescent (312) 312
disease models, animal (309) 309
research (309) 309
proteins (300) 300
disease (290) 290
analysis (280) 280
article (271) 271
neurodegeneration (262) 262
carrier proteins - genetics (258) 258
lysosomes - metabolism (254) 254
medicine, research & experimental (254) 254
clinical neurology (252) 252
metabolism (250) 250
medical research (248) 248
protein (247) 247
sphingomyelin phosphodiesterase - metabolism (245) 245
gene (241) 241
niemann-pick disease, type c - genetics (240) 240
mice, knockout (236) 236
niemann-pick c1 (232) 232
niemann-pick disease type c (230) 230
membrane glycoproteins - genetics (228) 228
medicine, experimental (225) 225
proteins - genetics (223) 223
fibroblasts - metabolism (221) 221
niemann-pick disease, type c - metabolism (221) 221
pediatrics (221) 221
fibroblasts (214) 214
niemann-pick diseases - enzymology (212) 212
lipid metabolism (208) 208
mice, inbred balb c (208) 208
sphingomyelin phosphodiesterase - genetics (208) 208
middle aged (205) 205
niemann-pick disease, type c - pathology (202) 202
transport (202) 202
diagnosis (201) 201
cell line (200) 200
medicine (200) 200
sphingomyelins - metabolism (199) 199
cells (197) 197
brain (196) 196
npc1 (195) 195
genetic aspects (187) 187
npc1 protein (186) 186
pathology (186) 186
phenotype (185) 185
disease type-c (181) 181
carrier proteins - metabolism (179) 179
physiological aspects (178) 178
research article (175) 175
enzymes (173) 173
homeostasis (173) 173
acid sphingomyelinase (172) 172
niemann-pick diseases - complications (171) 171
health aspects (169) 169
lysosomes (169) 169
mouse model (168) 168
biology (167) 167
hemic and lymphatic diseases (167) 167
brain - pathology (165) 165
neurons (161) 161
identification (160) 160
infant, newborn (159) 159
liver (159) 159
sphingomyelin phosphodiesterase - deficiency (159) 159
multidisciplinary sciences (158) 158
biophysics (156) 156
plasma-membrane (156) 156
nervous system diseases (155) 155
trafficking (155) 155
nutritional and metabolic diseases (153) 153
apoptosis (152) 152
ceramide (151) 151
niemann-pick diseases (151) 151
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4130) 4130
French (136) 136
German (87) 87
Japanese (65) 65
Spanish (39) 39
Russian (26) 26
Polish (23) 23
Chinese (20) 20
Italian (17) 17
Czech (16) 16
Portuguese (11) 11
Turkish (10) 10
Dutch (6) 6
Korean (6) 6
Hungarian (4) 4
Romanian (3) 3
Hebrew (2) 2
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1758 - 1768
Niemann-Pick disease, type C1 (NPC1) is a lysosomal storage disorder characterised by progressive neurodegeneration. In preclinical testing,... 
MIGLUSTAT THERAPY | STORAGE | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | CHOLESTEROL | BIOMARKER | CYCLODEXTRIN | CALBINDIN-D | PATIENT | BRAIN | CHILDREN | Injections, Spinal | Niemann-Pick Disease, Type C - drug therapy | 2-Hydroxypropyl-beta-cyclodextrin - adverse effects | Humans | Rare Diseases - drug therapy | Hearing Loss, High-Frequency - chemically induced | Child, Preschool | Niemann-Pick Disease, Type C - cerebrospinal fluid | Fatty Acid Binding Protein 3 - cerebrospinal fluid | Male | Biomarkers - blood | Hydroxycholesterols - cerebrospinal fluid | 2-Hydroxypropyl-beta-cyclodextrin - administration & dosage | Disease Progression | Dose-Response Relationship, Drug | Young Adult | Adolescent | Calbindins - cerebrospinal fluid | Female | Hydroxycholesterols - blood | Biomarkers - cerebrospinal fluid | Niemann-Pick Disease, Type C - blood | Child | Niemann-Pick disease | Medical research | Genetic disorders | Research & development--R&D | Clinical trials | Patients | Cholesterol | Studies | Cyclodextrin | Neurodegeneration | Biomarkers | Drug therapy | Drug dosages | Cerebellum | Slopes | Regulatory agencies | Animal models | Medical services | Childrens health | Hepatocellular carcinoma | Cognition | Cyclodextrins | Cerebrospinal fluid | Dosage | Proteins | Randomization | Npc1 protein | Bioindicators | Safety | Age | Health | FDA approval | Hearing loss | Domains | Medical centres | Life span | Hearing aids | Mastoiditis | Ototoxicity
Journal Article
Gut, ISSN 0017-5749, 06/2017, Volume 66, Issue 6, pp. 1060 - 1073
ObjectivePatients with Niemann–Pick disease type C1 (NPC1), a lysosomal lipid storage disorder that causes neurodegeneration and liver damage, can present with... 
IBD-GENETICS | IBD CLINICAL | IMMUNODEFICIENCY | IBD BASIC RESEARCH | Crohn'S DISEASE | MIGLUSTAT THERAPY | PATHOGENESIS | APOPTOSIS | DENDRITIC CELLS | MACROPHAGES | SUSCEPTIBILITY | ILEAL MUCOSA | PHAGOSOME PROTEOME | GASTROENTEROLOGY & HEPATOLOGY | BOWEL-DISEASE | INNATE IMMUNITY | Tumor Necrosis Factor-alpha - metabolism | Crohn Disease - genetics | X-Linked Inhibitor of Apoptosis Protein - deficiency | Humans | Child, Preschool | Lysosomes | Male | Nod2 Signaling Adaptor Protein - genetics | Leukocytes, Mononuclear | Pyridazines - pharmacology | Niemann-Pick Disease, Type C - physiopathology | Autophagy - drug effects | Crohn Disease - complications | Receptor-Interacting Protein Serine-Threonine Kinase 2 - metabolism | Young Adult | Gentamicins - pharmacology | Adult | Bacteria | Female | Genetic Diseases, X-Linked - genetics | Autophagy - genetics | Child | Receptor-Interacting Protein Serine-Threonine Kinase 2 - antagonists & inhibitors | Macrophages - physiology | Granuloma - genetics | Cells, Cultured | Chlorpromazine - pharmacology | Imidazoles - pharmacology | Acetylmuramyl-Alanyl-Isoglutamine - metabolism | X-Linked Inhibitor of Apoptosis Protein - genetics | Acetylmuramyl-Alanyl-Isoglutamine - pharmacology | Granuloma - pathology | Nod2 Signaling Adaptor Protein - metabolism | Crohn Disease - pathology | Dopamine Antagonists - pharmacology | Adolescent | X-Linked Inhibitor of Apoptosis Protein - metabolism | Macrophages - drug effects | Anti-Bacterial Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Mutation | Niemann-Pick Disease, Type C - complications | Niemann-Pick Disease, Type C - genetics | Autophagy (Cytology) | Inflammatory bowel diseases | Gastrointestinal diseases | Causes of | Colorectal diseases | Crohn's disease | Research | Niemann-Pick disease | Salmonella | Granuloma | Muramyl dipeptide | Liver | XIAP protein | Kinases | Macrophages | Autophagy | Defects | Genotype & phenotype | Cell activation | Intestine | Neurodegeneration | Npc1 protein | Age | NOD2 protein | Oligomerization | Dendritic cells | Cytokines | Blood & organ donations | Inflammation | Patients | Crohns disease | Studies | Inflammatory bowel disease | Monocytes | Proteomics | Colitis | Adapter proteins | Phagocytosis | Apoptosis | IBD - GENETICS | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506
Journal Article
Molecular Genetics and Metabolism, ISSN 1096-7192, 08/2016, Volume 118, Issue 4, pp. 304 - 309
There is current expansion of newborn screening (NBS) programs to include lysosomal storage disorders because of the availability of treatments that produce an... 
Pompe disease | Tandem mass spectrometry | Hurler disease | Gaucher disease | Lysosomal storage disorders | Krabbe disease | Niemann-Pick-A/B disease | Dried blood spot | Newborn screening | Fabry disease | MEDICINE, RESEARCH & EXPERIMENTAL | MUCOPOLYSACCHARIDOSIS-I | ASSAY | DISORDERS | CARDS | DRIED BLOOD SPOTS | RETROSPECTIVE DIAGNOSES | ENZYMES | FABRY | ENDOCRINOLOGY & METABOLISM | GENETICS & HEREDITY | FILTER-PAPER | ENZYMATIC DIAGNOSIS | Dried Blood Spot Testing | Glucosylceramidase - blood | Humans | Mucopolysaccharidosis I - physiopathology | Male | Gaucher Disease - blood | Neonatal Screening | Leukodystrophy, Globoid Cell - physiopathology | Tandem Mass Spectrometry | Fabry Disease - blood | Female | Gaucher Disease - physiopathology | Lysosomal Storage Diseases - blood | Galactosylceramidase - blood | Glycogen Storage Disease Type II - blood | Infant, Newborn | Lysosomal Storage Diseases - classification | Mucopolysaccharidosis I - blood | alpha-Glucosidases - blood | Niemann-Pick Diseases - blood | Lysosomal Storage Diseases - genetics | Enzyme Assays | Niemann-Pick Diseases - physiopathology | Lysosomal Storage Diseases - pathology | Glycogen Storage Disease Type II - physiopathology | alpha-Galactosidase - blood | Fabry Disease - physiopathology | Iduronidase - blood | Leukodystrophy, Globoid Cell - blood | Sphingomyelin Phosphodiesterase - blood | Medicine, Experimental | Medical research | Medical screening | Mass spectrometry | Niemann-Pick-A | B disease
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9813, pp. 335 - 341
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181700
Journal Article
Molecular and Cellular Neuroscience, ISSN 1044-7431, 2010, Volume 43, Issue 1, pp. 33 - 42
Journal Article